NEW YORK (GenomeWeb News) – Sequenom’s stock was by far the biggest gainer — more than doubling its price — in June among the 36 companies that comprise the GenomeWeb Daily News Index.
In a tough month for the stock market, in general, Sequenom’s shares rose 107.5 percent. On the other end of the spectrum, shares of Caliper Life Sciences continued to decline, falling 27.6 percent for the month of June.
As reported by GWDN on Wednesday, Sequenom’s shares hit a 52-week high of $17.52 during Wednesday trade on the Nasdaq, before closing at $17.37.
The San Diego-based firm’s shares have risen sharply over the past month after it said that a blinded study showed that its molecular test for Down syndrome correctly identified 100 percent of all Down syndrome samples without any false-positive outcomes.
Five other firms in the Index managed to record double-digit gains for the month. They include Bruker (+10.4 percent), Genomic Health (+10.7 percent), Illumina (+11 percent), Rosetta Genomics (+14.2 percent), and Nanogen (+15.1 percent).
The month of June, however, meant a decline in the value of many of the stocks in the Index with 23 of the 36 companies recording a drop in their share price.
Caliper led decliners for the month. The firm didn’t report any news for that period until it said on Monday that it had been added to the Russell 3000 Index.
Shares of the Hopkinton, Mass.-based firm have fallen more than 50 percent since the beginning of the year.
In addition to Caliper, two other firms in the Index had a loss of more than 20 percent for June: Accelrys (-25.9 percent) and Clinical Data (-25.4 percent).
Overall, the GWDN Index declined 3.5 percent for the month of June. In comparison, the Dow Jones Industrial Average tumbled 10.2 percent, the Nasdaq sank 9.1 percent, and the Nasdaq Biotech Index lost 3 percent.
While GenomeWeb Daily News covers many more firms than are in the Index, those that have been included have a significant portion of their business focused on molecular biology and cellular research tools and are publicly traded in the US.
GenomeWeb Daily News Index
(June 30, 2008)
(May 30, 2008)
|GWDN Index Average||26.99||